Peer-influenced content. Sources you trust. No registration required. This is HCN.

Oncology News Central (ONC)“Surprising” Divide Between Physicians and Patients in CML Treatment Choices

The CML SUN study surveyed 361 CML patients and 198 physicians and found gaps in shared decision-making during treatment selection.


Chronic myeloid leukemia (CML) treatment decisions could significantly benefit from an increased level of shared decision-making between physicians and patients, according to the latest findings from the CML SUN study presented at the EHA 2023 Congress.

Key Points

  • Patients aim to maintain or improve their quality of life, manage adverse effects, and halt disease progression.
  • 39%-43% of patients indicated that their physician only described one treatment option, while only 19%-26% of patients reported a joint decision-making process.
  • Despite 69% of physicians stating that they inform patients about treatment options, 48%-66% only provide information about one treatment option.
  • 44%-48% of physicians reported making treatment decisions with minimal patient input. 74% of physicians see themselves as the ultimate decision-makers.

Additional Points

  • Although most patients and physicians are satisfied with the efficacy of current treatments, many patients reported that their treatments impacted their quality of life.
  • Patients reported physical (78%) and emotional (69%) fatigue, reduced ability to exercise (66%), and stress about whether the treatment was effective (58%).

Conclusion

  • The CML SUN study findings underscore the need for shared decision-making in CML treatment, balancing efficacy and tolerability. There appears to be a lack of patient empowerment in the treatment decision process.

Hematology/Oncology Further Reading

“Information is power. The more a patient knows and understands, the easier I find navigating complex decisions is, the higher the level of patient comfort is, and the better the relationship can be.”

Dr. Michael Mauro
Memorial Sloan Kettering Cancer Center
The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form